Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold a total of 5,844 shares of the company's common stock on February 13, 2025, according to a recent SEC filing. The ...

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.

Highlights,Guggenheim raised Tapestry's target price from $70 to $90, signaling increased market confidence.,The company ...

An "unsinkable" ship can still sink. Read on for more facts about what happened on the 'Titanic,' from its famous passengers ...